The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Phase II pharmacodynamic trial of palbociclib in patients with KRAS mutant colorectal cancer.
 
Mark H. O'Hara
No Relationships to Disclose
 
Christine Edmonds
No Relationships to Disclose
 
Michael Farwell
No Relationships to Disclose
 
Rodolfo F. Perini
Employment - Merck
 
Daniel A. Pryma
No Relationships to Disclose
 
Ursina R. Teitelbaum
No Relationships to Disclose
 
Bruce J. Giantonio
No Relationships to Disclose
 
Nevena Damjanov
No Relationships to Disclose
 
Priti Lal
No Relationships to Disclose
 
Michael D Feldman
No Relationships to Disclose
 
Paul J. Zhang
No Relationships to Disclose
 
David A. Mankoff
No Relationships to Disclose
 
Maryann Gallagher
No Relationships to Disclose
 
Angela DeMichele
Research Funding - Genentech (Inst); Incyte (Inst); Pfizer (Inst); Roche (Inst)
Travel, Accommodations, Expenses - Pfizer
 
David J. Vaughn
No Relationships to Disclose
 
Peter J. O'Dwyer
Research Funding - Bristol-Myers Squibb; GlaxoSmithKline; Lilly; Merck; MethylGene; Pfizer